{"id":"NCT00727649","sponsor":"US Department of Veterans Affairs","briefTitle":"Efficacy and Mechanisms of Pharmacologic Treatment of Fecal Incontinence","officialTitle":"Efficacy and Mechanisms of Pharmacologic Treatment of Fecal Incontinence","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2008-07","primaryCompletion":"2013-10","completion":"2013-12","firstPosted":"2008-08-04","resultsPosted":"2015-04-01","lastUpdate":"2015-04-01"},"enrollment":80,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Fecal Incontinence"],"interventions":[{"type":"DRUG","name":"Psyllium powder","otherNames":["Metamucil"]},{"type":"DRUG","name":"Loperamide","otherNames":[]}],"arms":[{"label":"Arm 1","type":"ACTIVE_COMPARATOR"},{"label":"Arm 2","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to evaluate and compare treatment with fiber and loperamide for fecal incontinence.","primaryOutcome":{"measure":"7-day Bowel Diary, Number of Fecal Incontinence Episodes","timeFrame":"6 weeks and 12 weeks","effectByArm":[{"arm":"P1L2 (Psyllium First, Then Loperamide)","deltaMin":7.3,"sd":6.2},{"arm":"L1P2 (Loperamide First, Then Pysllium)","deltaMin":7.9,"sd":7.5}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":9},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":34},"commonTop":["excessive flatus","abdominal pain","diarrhea","constipation","bloating"]}}